EpiBiologics
Pre-clinicalEpiBiologics develops targeted protein degradation therapies using proprietary antibody-based platforms.
Founded
2020
Focus
AntibodiesBiologics
About
EpiBiologics develops targeted protein degradation therapies using proprietary antibody-based platforms.
Funding History
2Total raised: $100M
Series A$50MMubadala CapitalOct 15, 2023
Seed$50MMubadala CapitalJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile